Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical organizations, which includes the makers of Xarelto, possess a duty to ensure that their drugs are reasonably secure for use - and failure to do so could be grounds for compensation. Our lawyers are operating difficult to get those hurt by the drug the compensation they are entitled to.<br><br> <br><br> Although bleeding is actually a common complication connected with anticoagulants, it has been alleged that Xarelto is a lot more unsafe than standard blood thinners simply because no antidote exists to reverse its blood-thinning effects. This implies that, within the occasion of an emergency, patients might be at threat for irreversible bleeding problems, which includes life-threatening internal and gastrointestinal hemorrhaging.<br><br> <br><br> If you or perhaps a loved 1 suffered a significant bleeding event soon after taking Xarelto, you might have legal recourse. For much more information, make contact with us right now to have your case reviewed, totally free of charge.<br><br> Compensation Possibilities<br><br> <br><br> xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future healthcare bills, lost wages, discomfort and suffering and, in situations of death, funeral expenditures. In addition, they may be searching for punitive damages, which are generally awarded to punish the defendant and deter other businesses from acting similarly.<br><br> Why Are Lawsuits Getting Filed?<br><br> <br><br> Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs within the lawsuits allege significant and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.<br><br> <br><br> In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:<br><br> <br><br> The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.<br><br> The makers of the drug continue to market Xarelto as a secure anticoagulant option.<br><br> Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.<br><br> Users of Xarelto - http://www.nuwireinvestor.com/results.aspx?searchwords=Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.<br><br> Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.<br><br> <br><br> Visit this page for far more data on the alleged health risks of Xarelto.<br><br> Multidistrict Litigation Trial Dates Set<br><br> <br><br> The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which is better xarelto or eliquis - http://xareltolawyers.bitbucket.org/categories/Wyoming/Xarelto-Stroke-Lawsuit-Jackson-WY-83025.html currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.